Celebrating Women Leading Innovation in Biopharma
- Date: Wednesday June 18th
- Time: 1:15 PM - 2:15 PM ET
- Location: Boston Convention & Exhibition Center Room 208
Recent data reveals that less than 10% of CEOs in the biopharma industry are women, while female representation in leadership teams stands at 25%. However, the momentum for change is undeniable. A growing number of female leaders are driving innovation and shaping the future of healthcare, demonstrating the powerful impact of women at the forefront of the industry. This panel will spotlight glass shattering female CEOs who are not just leading biotech companies – they are reshaping the future of healthcare. These leaders are leveraging their unique perspectives to foster innovation, develop patient-focused solutions, and push their companies forward in an increasingly competitive industry. Attendees will gain firsthand insights into the pivotal moments and bold decisions that have propelled these leaders to the forefront of biopharma. From startup funding to empowering women in life sciences and tackling gender disparities in research and healthcare, this panel will explore how female-led innovation is transforming healthcare and setting new standards for excellence.
Meet the panelists & Moderator

Nicole DeFeudis
Editor, Endpoints News

Judy Chou, PhD
President and CEO, AltruBio

Angela Hwang, MBA
CEO, Metaphore Biotechnologies

Elizabeth Jeffords
President & CEO, Iolyx Therapeutics

Sabrina M. Johnson
President and CEO, Daré Bioscience

Daisy Robinton, PhD
Co-Founder & CEO, Oviva Therapeutics
BIO International 2025
Bringing together industry experts to discuss the next wave of innovation in biotech.
See more with LifeSci Communications
We are committed to helping our partners transform complex science into moving stories that demand—and get—attention.